Search Results - "Cunquero Tomas, Alberto Jacobo"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    Unexpected pure red series aplastic anemia secondary to pembrolizumab treatment: a case report and literature review by Meri-Abad, Marina, Cunquero Tomás, Alberto Jacobo, Jaime, Alfonso Berrocal

    Published in Melanoma research (01-04-2021)
    “…Pembrolizumab is a treatment that has shown a survival benefit in patients with metastatic melanoma. Programmed death receptor 1 inhibitors are new therapeutic…”
    Get full text
    Journal Article
  4. 4

    Impact of burn-out syndrome in oncology staff and its improvement through specific interventions by Cunquero Tomas, Alberto Jacobo, Ortega, Inmaculada, Fernández, Teresa, Lobo De Mena, Miriam, Gil Raga, Mireia, Iranzo, Vega, Caballero Diaz, Cristina, Gomez, Ana, Blasco, Ana, Camps, Carlos

    Published in Journal of clinical oncology (20-09-2019)
    “…Abstract only 249 Background: Burn-Out Syndrome (BOS) is defined by: emotional and physical exhaustion; cynicism and depersonalization; and no personal nor…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Unexpected pure red series aplastic anemia secondary to pembrolizumab treatment: a case report and literature review by Meri-Abad, Marina, Cunquero Tomás, Alberto Jacobo, Jaime, Alfonso Berrocal

    Published in Melanoma research (18-02-2021)
    “…Pembrolizumab is a treatment that has shown a survival benefit in patients with metastatic melanoma. Programmed death receptor 1 inhibitors are new therapeutic…”
    Get full text
    Journal Article
  11. 11

    Oncologist liaison: Satisfaction and symptoms in cancer long survivors by García Navalón, Francisco Javier, Monfort García, Rosa, Cunquero Tomás, Alberto Jacobo, Umanzor Funez, Gerardo Antonio, Palomar Coloma, Virginia, Iranzo, Vega, Blasco, Ana, Camps, Carlos

    Published in Journal of clinical oncology (01-11-2014)
    “…Abstract only 251 Background: Each year, the prevalence of cancer long survivors (CLS) increases; defined as a person who after five years of diagnosis and…”
    Get full text
    Journal Article